|
 |
2009/05/06/FDA APPROVES NEW MEDTRONIC LEFT HEART LEAD FOR CARDIAC WELT ONLINE/
The page is no longer available. You may want to read the following pages.
BD Mitchell, H Shen, K Shields... - Archives of Internal ..., 2011 - Am Med Assoc Comment. As residents' work hours are restricted, it is important to understand out-of-hospital
work. Elec- tronic health records have allowed many residents to com- plete clinical tasks from
home, which are not routinely counted as part of duty hour reports. Moreover, this work is ...
M Cucherat... - American Journal of Therapeutics, 2011 - Background: The benefit of heart rate (HR) reduction in patients with stable coronary artery disease
is well demonstrated for symptom prevention and relief, and benefits on outcomes are being
actively investigated. We aimed to quantify the reduction in resting HR induced by 5 ...
KC Yang, PY Jay... - Cardiovascular ..., 2011 - Abstract Aims: Cardiac hypertrophy and heart failure are associated with QT prolongation and lethal ventricular arrhythmias, resulting from decreased K+ current densities and impaired repolarization. Recent studies in mouse models of physiological cardiac ...
DA Leonard, ME Merhige, BA Williams... - Coronary Artery ..., 2011 - Objectives: As accumulation of monocytes and macrophages is a feature of atherosclerotic plaque at all stages, inflammatory gene expression profiling of peripheral blood mononuclear cells may provide a more reliable measure of atherogenesis than systemic ...
JN COHN... - Recherche, 2012 - In the joint American College of Cardiology/American Heart Association classification system, Stage B heart failure refers to patients with structural heart disease but no symptoms of heart failure. Preventing progression of heart failure in Stage B patients is a central ...
|
|
|
